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Introduction
A great deal of what we know about human biology is derived from animal studies. In some cases, such as study of cancer, is only possible to carry out studies using animal models. Better understanding of the mechanisms regulating the development, progression, and spread of colorectal tumors are required to obtain adequate animal models.
The introduction of athymic mice in the '60s was followed by great possibilities in research of implantable tumor models 1, 2 . Understanding these models, accepting their limitations and improving its features are important and necessary for research development. These models offer not only increase understanding about the mechanism involved in pathogenesis, but also enable the development of anticancer therapies.
Currently, the most widely used animal model in cancer research is the athymic mouse. This use is mainly due to ideal characteristics, which include rapid tumor growth, easy handling, and the ability to accept human cells. Athymic mice have been used as an important biomedical tool 1, 2, [3] [4] [5] [6] [7] [8] [9] [10] . Athymic mice accept xenogeneic and allogeneic grafts, including those of malignant tumors, because they are immunocompromised. Malignant tumor transplantation in athymic mice has been widely used in many type of cancer research, because the animal can maintain the original histological features of the tumor such as karyotype, expression of oncogenes, molecular structure and clonal evolution 3 . However,
there is concern about the interaction between the tumor and the microenvironment. This issue not will be solved with the continued use of xenograft models, particularly heterotopic type.
Subcutaneous inoculation models can easily be established and is convenient for tumor observation. However, this site does not represent the local conditions of tumor origin. 6, 7, 8, 9 . However, real-time observation and repeated sampling of implanted tumor is difficult to achieve in those model.
This disadvantage was solved in 2009 with cecostomy model 8 .
Although the incidence is modifying, most colorectal cancers arise in the distal colon, so, a distal colon cancer models is desirable. Thus, the aim of this study was to present a novel model of cancer in distal colon that allows a real-time observation and could be suitable for studying the tumor evolution with implementation of cytotoxic therapy, by macroscopy, microscopy and scintigraphic detection, in vivo.
Methods
In this study were used eight-week old mice (Balb/c nu/ nu) from Charles River, Spain. supplemented with 100 μM sodium pyruvate (Gibco-11-360), 10% fetal bovine serum (Gibco 2010-09) and 1% antibiotic (100 U/ml penicillin and 10 μg/mL streptomycin, Gibco 15140-122).
The tumor cell cultures were incubated with 3 mL of Trypsin-EDTA, 0.25% (Gibco 25 200), for three minutes to allow cell separation. The culture medium was changed every 24 hours.
The viability of the cells were determined using a Neubauer chamber and were evaluated by the exclusion of Trypan blue.
Surgical technique
Colon diversion was performed with a proximal colostomy and distal fistula. First, the abdominal cavity was opened (Figure 1 ). Abdominal wall was closed in layers, aponeurosis and skin, with 6-0 cotton thread, 7 mm needle, triangular.
Tumor cell inoculation
Seven days after surgery, the tumor cells were suspended in 40 μl of normal saline and 4X10 6 cells were directly seeded into the submucosa of fistula using a 1ml syringe with a hypodermic 30-gauge needle.
Postoperative time
After the operation, animals were housed in individual cage. After fully awaking from surgery, they were subjected to standard water and chow until the time of death. Animals were monitored after inoculation daily.
Imaging with 99mTc-methoxyisobutylisonitrile (MIBI)
Animals were anesthetized as previous described.
MIBI injection was performed in the dorsal tail vein.
Immediately after, acquisitions with a dynamic gamma camera (GE 400 AC) were started. The computer software GenieAcq controlled acquisition and it was made in two sequential phases.
During the dynamic phase, images were taken every 30 seconds for five minutes. Then, static images were obtained at 10, 30, 60, and 90 minutes. These images were acquired and then processed by Xeleris workstation.
Histopathologic analysis
Tumor resection was performed. The excised specimen was fixed in formaldehyde, embedded in paraffin block and subjected to longitudinal sections. The slides were then stained with hematoxylin-eosin. The presence and degree of differentiation of tumor were determined.
Results
Tumor was grown in three of seven animals seeded. Four days after cell inoculation, tumor vision was macroscopically possible. The day after, tumor detection was possible by molecular imaging with MIBI. Tumors were identified as areas with increased uptake at 10 minutes after radiopharmaceutical injection ( Figure 3 ). All tumors presented ulcerative growing. In one case has occurred colon obstruction 21 days after tumor cells inoculation.
Metastasis was not found.
Discussion
To gain confidence in the validity of research using the animal model, clear and convincing data are needed. Few studies have used orthotopic model in distal colon 15, 16, 17 . Tumor measurement and tumor tissue collection are neither easy nor accurate, consequently, this model is seldom used.
In this study, the tumor implanted at the fistula 
Conclusion
Orthotopic model of distal colon is feasible, allows monitoring the tumoral growth by molecular imaging and is suitable for studying the evolution with implementation of cytotoxic therapy in real time.
